AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture and sale of pharmaceutical products. The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products/services of the Company are Meronem and Brilinta/Axcer. Its pipeline includes products, such as AZD4076, MEDI6012, AZD2811, MEDI0680, selumetinib, anifrolumab and MEDI7510. Its brands include Crestor, Seloken XL, Meronem, Arimidex, Zoladex, Nexium and Brilinta.